Share Email Print
cover

Proceedings Paper

Latest results of 5-ALA-based fluorescence diagnosis and other medical disciplines
Author(s): Reinhold Baumgartner
Format Member Price Non-Member Price
PDF $14.40 $18.00

Paper Abstract

Preclinical and clinical studies on 5-aminolevulinic acid (5- ALA) induced Protoporphyrin IX (PPIX) are performed in various departments now following promising clinical results for the detection of bladder cancer in urology. This paper provides an overview on the progress of 5-ALA assisted fluorescence diagnosis in urology, pulmonology, neurosurgery, gynecology and ENT coordinated by the Laser Research Laboratory of the Ludwig-Maximilians-University in Munich. 5-ALA can be applied either topically or systematically to induce an intracellular accumulation of fluorescing PPIX. With appropriate dosage of 5-ALA, malignant tissue can be stained selectively, and irradiation with violet light excites a bright red fluorescence of the tumor visible with naked eyes. Optical properties of the tissue tend to hamper the precise identification and demarcation of suspect areas in fluorescence images. Multicolor remission and fluorescence imaging, therefore, should improve tumor localization in future.

Paper Details

Date Published: 3 February 1999
PDF: 10 pages
Proc. SPIE 3563, Photochemotherapy of Cancer and Other Diseases, (3 February 1999); doi: 10.1117/12.339124
Show Author Affiliations
Reinhold Baumgartner, Urologische Klinik/Ludwig-Maximilians-Univ. Muenchen (Germany)


Published in SPIE Proceedings Vol. 3563:
Photochemotherapy of Cancer and Other Diseases
Benjamin Ehrenberg; Kristian Berg, Editor(s)

© SPIE. Terms of Use
Back to Top